(Q26999394)

title

Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review (English)

1 reference

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Jindřich Kopecký

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Petronela Trojanová

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Otakar Kopecký

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

1 reference

April 2015

1 reference

Japanese Journal of Clinical Oncology

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

45

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

381-384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

Management of immune-related adverse events and kinetics of response with ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

International consensus report on the investigation and management of primary immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYU222

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYU222

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583422%20AND%20SRC:MED&resulttype=core&format=json